Education
About Us
Working with TipRanks
Follow Us
Telo Genomics (TSE:TELO)
:TELO
RESEARCH TOOLSreports
TELO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.23
Previous CloseN/A
Volume60.50K
Average Volume (3M)95.87K
Market Cap
C$9.00M
Enterprise ValueN/A
Total Cash (Recent Filing)C$2.25M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Nov 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding100,018,936
10 Day Avg. Volume25,336
30 Day Avg. Volume95,868
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)4.83
Price to Sales (P/S)0.00
P/FCF Ratio-5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Telo Genomics Corp News
PremiumCompany Announcements
Telo Genomics Advances IP Strategy with New Tier Status from IPON
PremiumCompany Announcements
Telo Genomics’ SMM Risk Prediction Abstract Accepted for EHA 2025 Congress
PremiumCompany Announcements
Telo Genomics’ MRD Data in Multiple Myeloma Gains ASCO Recognition
PremiumCompany Announcements
Telo Genomics Strengthens Leadership with New Board Appointment
PremiumCompany Announcements
Telo Genomics Strengthens Leadership with New Executive Chairman
PremiumCompany Announcements
Telo Genomics Secures $2.5 Million in Oversubscribed Placement
PremiumCompany Announcements
Telo Genomics Approved for Ontario IP SupportOptions Prices
Currently, No data available
---
Ownership Overview
0.15% Insiders
―
Mutual Funds
― Other Institutional Investors
99.85% Public Companies and
Individual Investors
TELO FAQ
What was Telo Genomics’s price range in the past 12 months?
Telo Genomics lowest stock price was C$0.07 and its highest was C$0.23 in the past 12 months.
What is Telo Genomics’s market cap?
Telo Genomics’s market cap is C$9.00M.
When is Telo Genomics’s upcoming earnings report date?
Telo Genomics’s upcoming earnings report date is Nov 04, 2025 which is in 145 days.
How were Telo Genomics’s earnings last quarter?
Telo Genomics released its earnings results on May 27, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is Telo Genomics overvalued?
According to Wall Street analysts Telo Genomics’s price is currently Overvalued.
Does Telo Genomics pay dividends?
Telo Genomics does not currently pay dividends.
What is Telo Genomics’s EPS estimate?
Telo Genomics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telo Genomics have?
Telo Genomics has 100,018,936 shares outstanding.
What happened to Telo Genomics’s price movement after its last earnings report?
Telo Genomics reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Telo Genomics?
Currently, no hedge funds are holding shares in TSE:TELO
Company Description
Telo Genomics
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.